Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma. (Record no. 10801453)

MARC details
000 -LEADER
fixed length control field 01579 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513212608.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200007s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1084-9785
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1089/cbr.1998.13.165
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dillman, R O
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20000706
245 00 - TITLE STATEMENT
Title Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer biotherapy & radiopharmaceuticals
Date of publication, distribution, etc. Jun 1998
300 ## - PHYSICAL DESCRIPTION
Extent 165-76 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element BCG Vaccine
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Vaccines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Culture Techniques
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Granulocyte-Macrophage Colony-Stimulating Factor
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypersensitivity, Delayed
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferons
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nayak, S K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Barth, N M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name DeLeon, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schwartzberg, L S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spitler, L E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Church, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Connor, A A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Beutel, L D
773 0# - HOST ITEM ENTRY
Title Cancer biotherapy & radiopharmaceuticals
Related parts vol. 13
-- no. 3
-- p. 165-76
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1089/cbr.1998.13.165">https://doi.org/10.1089/cbr.1998.13.165</a>
Public note Available from publisher's website

No items available.